Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders

Details for Australian Patent Application No. 2005205531 (hide)

Owner ARYx Therapeutics

Inventors Becker, Cyrus; Irwin, Ian; Druzgala, Pascal; Palme, Monica; Rubens, Courtney

Agent Spruson & Ferguson

Pub. Number AU-B-2005205531

PCT Pub. Number WO2005/068461

Priority 60/534,892 07.01.04 US; 60/560,938 09.04.04 US

Filing date 7 January 2005

Wipo publication date 28 July 2005

Acceptance publication date 17 March 2011

International Classifications

C07D 453/02 (2006.01) Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids

C07D 211/94 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 451/10 (2006.01) Heterocyclic compounds containing condensed hetero ring systems

Event Publications

27 July 2006 PCT application entered the National Phase

  PCT publication WO2005/068461 Priority application(s): WO2005/068461

31 August 2006 Amendment Made

  The nature of the amendment is: Add co-inventor Druzgala, Pascal and Rubens, Courtney

17 March 2011 Application Accepted

  Published as AU-B-2005205531

14 July 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005205533-M-CSF-specific monoclonal antibody and uses thereof

2005205527-Catalyst compositions and polyolefins for extrusion coating applications